Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 56 days for 2021).
- 202508/07/2026
- 202416/07/2025
- 202304/07/2024
- 202217/07/2023
- 202109/09/2022
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Aptecom Nova has been an NFZ healthcare provider since 2010. In 2026 it is performing 4 contracts with a total value of USD 135.06. All its contracts were worth USD 135.06 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Pilot programmes | zachodniopomorskie | 1 | USD 135.06 |
| Provision of medical devices | zachodniopomorskie | 1 | USD 0.00 |
| Other services provided in pharmacies | zachodniopomorskie | 2 | USD 0.00 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Lidia Ligarskaage 64 | 500 | $6,753.11 | 50% |
Kazimierz Szczepan Ligarskiage 64 | 500 | $6,753.11 | 50% |
Kazimierz Szczepan Ligarski and Lidia Ligarska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-12-08.
51 1020 2791 0000 7602 0228 0048
29 1090 2590 0000 0001 3067 9524
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $76,402.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 12, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3$3 | Energa - Obrót S.A. | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,956$2,956 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 10, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $68,109$68,109 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-01-11 | Share capital change (25,450.00 PLN → 50,000.00 PLN) | |
| 2015-10-19 | Share capital change (5,000.00 PLN → 25,450.00 PLN) | |
| 2015-10-19 | PKD change (Removed: 20.41, 20.42, 21.10, 21.20, 47.73, 47.74, 47.75, 47.91, 47.99, 68.10, 68.20, 68.32, 70.22, 73.11; Added: 20.42.Z, 21.10.Z, 21.20.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 68.20.Z, 73.11.Z) | |
| 2014-11-24 | Entered in the register |
FAQ
Last updated: 2026-07-15